MENDΛERA

A Robot Small Enough to Hold

The most expensive robots in medicine live in operating rooms, cost millions of dollars, and spend a surprising amount of time idle. They are extraordinary machines for a narrow set of extraordinary procedures. Mendaera, a healthcare technology company founded in San Mateo in 2020, noticed the more interesting number: the enormous pile of ordinary procedures - the biopsies, the drains, the vascular access, the kidney-stone punctures - that are done freehand, millions of times a year, with a steady hand and a hope.

Needles are the workhorse tool of medicine, and precision with them has historically been a matter of the operator's skill on the day. Mendaera's proposition is that this is a solvable problem, and that the solution does not have to weigh a ton or fill a room. The company builds Focalist, a handheld robotic system - roughly fist-sized - that combines real-time ultrasound imaging, robotic needle positioning, touchscreen targeting, and continuous depth-tracking. You point it, you confirm the target on a screen, and the robotics handle the part where being off by a few millimeters matters.

This is a deliberately unglamorous bet. Nobody makes a movie about a device that helps a clinician hit a vein on the first try. But the economics are the whole point: a smaller, cheaper, more portable robot can go where the big systems can't, and it can address the procedures that actually make up the bulk of the day. The pitch to a hospital is not "do something you've never done." It's "do the thing you do constantly, more reliably, with fewer retries."

There's a reason to take the bet seriously beyond the elegance of the idea, and his name is Dr. Fred Moll. Moll co-founded Intuitive Surgical, maker of the da Vinci system that essentially created the surgical-robotics category, and later co-founded Auris Health, acquired by Johnson & Johnson. When the person who built the big robots writes a check for the small one, it's worth reading as a thesis: the last two decades of medical robotics were about capability and scale. The next, Mendaera is wagering, is about access.

What Focalist Actually Does

Strip away the category talk and Focalist is a device that helps a clinician put a needle exactly where they intend to. It does this by fusing three things that usually live separately: the imaging that shows where the target is, the robotics that steady and position the needle, and the software that lets the operator confirm the plan before anything moves.

The strategy runs deeper than a single gadget. Around 2023, Mendaera acquired the technology of Avail Medsystems, a medical-telepresence company. On its face, buying video-conferencing tech is an odd move for a robotics startup - until you notice that a cloud-connected handheld robot can be supported, guided, and learned from remotely. The device is the beginning; the connected platform is the ambition.

Who's Backing the Small Robot

Mendaera didn't raise money to ship a product; it raised money to build a category. The roughly $97M in total funding is aimed at establishing mainstream robotic intervention - a market defined not by how impressive one procedure is, but by how many procedures the device can eventually touch.

The Series B was led by Threshold Ventures, with participation from Lux Capital, PFM Health Sciences, Founders Fund, Puma Venture Capital, and Dr. Fred Moll - the Intuitive and Auris co-founder who also backed the Series A. It's an investor list that reads less like a bet on a device and more like a bet on the people who know exactly how hard this is.

The Short Answers